ATLASAnaptysBio (ANAB) earnings date: Nov 3, 2026
AnaptysBio (ANAB) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of $0.41.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ANAB
| Last price | $47.68 (-1.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.0% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the AnaptysBio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
AnaptysBio reports on Nov 3, 2026. One email the day before, with ATLAS’s read on AnaptysBio. You can switch it off at any time.
Alert me before ANAB reportsFree to start. Creating an account takes under a minute.
Notify me when AnaptysBio reports
Track ANAB free Add AnaptysBio to a free ATLAS watchlist and see its next report date in one place.
ANAB earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | $0.41 |
| Last report | Sep 21, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +65.4% |
| Average move around a report | ±6.7% (last 5) |
| Sector | Healthcare · Biotechnology |
AnaptysBio earnings history: last 5 reports
AnaptysBio last reported on Sep 21, 2026: EPS of -$0.11 against an estimate of -$0.46 (+76.1% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 21, 2026 | -$0.46 | -$0.11 | +76.1% | Beat | -2.3% |
| May 29, 2026 | $0.74 | $0.92 | +24.3% | Beat | -6.8% |
| Mar 3, 2026 | $0.93 | $1.58 | +69.9% | Beat | +10.3% |
| Nov 4, 2025 | -$1.25 | $0.52 | +141.6% | Beat | -0.1% |
| Aug 6, 2025 | -$1.58 | -$1.34 | +15.2% | Beat | -14.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ANAB
See the fair value, the probability range and the earnings history of AnaptysBio on its ATLAS page.
AnaptysBio (ANAB) stock analysisPlans from €3.99 a month.
AnaptysBio earnings: frequently asked questions
When does AnaptysBio (ANAB) report earnings?
AnaptysBio is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ANAB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is $0.41 per share (USD). Estimates can change before the report.
How often does ANAB beat earnings estimates?
Of its last 5 reports with a recorded result, AnaptysBio beat the EPS estimate 5 times; the average surprise was +65.4%. Past results do not predict the next one.
How much does ANAB move around earnings?
Over its last 5 reports the stock moved an average of 6.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did AnaptysBio beat earnings estimates last quarter?
AnaptysBio last reported on Sep 21, 2026: EPS of -$0.11 against an estimate of -$0.46 (+76.1% surprise), a beat.
How much does ANAB usually move in a day?
On a normal trading day the ATLAS model puts ANAB’s one-day range at about ±3.0%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer